Acromegaly caused by a growth hormone-releasing hormone secreting carcinoid tumour of the lung: the effect of octreotide treatment

Neth J Med. 2007 Jul-Aug;65(7):263-6.

Abstract

In acromegaly, the overproduction of growth hormone is usually caused by a pituitary adenoma. We report a 74-year-old woman with acromegaly caused by ectopic overproduction of growth hormone-releasing hormone (GHRH), a rare diagnosis. The GHRH appeared to be produced by a carcinoid tumour of the lung. Treatment with monthly long-acting octreotide resulted in a reduction in the symptoms and normalisation of the insulin-like growth factor-I, which has been maintained for more than two years now. A review of literature concerning causes and treatment of ectopic GHRH-producing tumours is presented.

Publication types

  • Case Reports

MeSH terms

  • Acromegaly / drug therapy
  • Acromegaly / etiology*
  • Acromegaly / physiopathology
  • Aged
  • Antineoplastic Agents, Hormonal / administration & dosage
  • Carcinoid Tumor / complications
  • Carcinoid Tumor / metabolism*
  • Female
  • Growth Hormone-Releasing Hormone / adverse effects*
  • Growth Hormone-Releasing Hormone / biosynthesis
  • Humans
  • Lung Neoplasms / complications
  • Lung Neoplasms / metabolism*
  • Octreotide / administration & dosage
  • Treatment Outcome

Substances

  • Antineoplastic Agents, Hormonal
  • Growth Hormone-Releasing Hormone
  • Octreotide